Sign in

CIK 0001806952

  • Non-accelerated filer
  • Smaller reporting company

Lyell Immunopharma, Inc.

Sign in to watch
Ticker
LYEL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
833006753
Phone
+1 650-695-0677
Business address
201 HASKINS WAY, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$49,999,983
in 2 filings
Open-market sales, last 90 days
$215,781
in 9 filings

Net +$49,784,202. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 41 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-02-10 Bulis Veronica Sanchez VP, Corporate Controller Grant or award +8,750 15,891
2026-02-10 Bulis Veronica Sanchez VP, Corporate Controller Sale −254 $23.12 $6K 15,637
2026-02-10 Shook David Chief Medical Officer Grant or award · Option (right to buy) +50,000 50,000
2026-02-10 Lee Gary K. Chief Scientific Officer Sale −147 $23.12 $3K 18,609
2026-02-10 Lee Gary K. Chief Scientific Officer Grant or award · Option (right to buy) +50,000 50,000
2026-02-10 Hill Stephen J. Chief Operating Officer Sale −109 $23.12 $3K 19,031
2026-02-10 Hill Stephen J. Chief Operating Officer Grant or award · Option (right to buy) +65,000 65,000
2026-02-10 Meltz Mark A General Counsel Grant or award · Option (right to buy) +50,000 50,000
2026-02-10 Seely Lynn President and CEO Sale −438 $23.12 $10K 81,721
2026-02-10 Seely Lynn President and CEO Grant or award · Option (right to buy) +155,000 155,000
2026-02-09 Lee Gary K. Chief Scientific Officer Grant or award +4,000 18,756
2026-02-09 Hill Stephen J. Chief Operating Officer Grant or award +4,000 19,140
2026-02-09 Seely Lynn President and CEO Grant or award +20,000 82,159
2025-12-30 Bulis Veronica Sanchez VP, Corporate Controller Sale −936 $32.32 $30K 7,141
2025-12-24 Bulis Veronica Sanchez VP, Corporate Controller Sale −1,136 $38.67 $44K 8,077
2025-11-10 Bulis Veronica Sanchez VP, Corporate Controller Sale −239 $16.10 $4K 9,213
2025-11-10 Lee Gary K. Chief Scientific Officer Sale −138 $16.16 $2K 15,366
2025-11-10 Hill Stephen J. Chief Operating Officer Sale −95 $16.12 $2K 15,750
2025-11-10 Seely Lynn President and CEO Sale −412 $16.11 $7K 67,159
2025-10-27 Lee Gary K. Chief Scientific Officer Grant or award · Option (right to buy) +68,000 68,000

Page 3 of 8 · 156 trades